These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 8486197

  • 1. Response to intermittent RU486 in women.
    Spitz IM, Croxatto HB, Salvatierra AM, Heikinheimo O.
    Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
    [Abstract] [Full Text] [Related]

  • 2. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O, Gordon K, Williams RF, Hodgen GD.
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [Abstract] [Full Text] [Related]

  • 4. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 5. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen SS.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [Abstract] [Full Text] [Related]

  • 6. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE, Kettel LM, Yen SS.
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [Abstract] [Full Text] [Related]

  • 7. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST, Thong KJ, Baird DT.
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [Abstract] [Full Text] [Related]

  • 8. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation.
    Kekkonen R, Croxatto HB, Lähteenmäki P, Salvatierra AM, Tuominen J.
    Hum Reprod; 1995 Feb; 10(2):287-92. PubMed ID: 7769050
    [Abstract] [Full Text] [Related]

  • 9. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 10. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R, Messinis LE, Fowler P, Groome NP, Knight PG, Templeton AA.
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [Abstract] [Full Text] [Related]

  • 11. Effects of a sequential regimen of mifepristone-medroxyprogesterone acetate on ovarian function, endometrial development and hormonal parameters.
    Croxatto HB, Massai MR, Salvatierra AM, Fuentealba B, Croxatto HD, Lähteenmäki P.
    Contraception; 1996 Aug; 54(2):79-86. PubMed ID: 8842583
    [Abstract] [Full Text] [Related]

  • 12. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B, Zeng T, Wu S, Sun H, Xiao N.
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [Abstract] [Full Text] [Related]

  • 13. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
    Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 16. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1977 Nov 01; 129(5):557-64. PubMed ID: 910845
    [Abstract] [Full Text] [Related]

  • 17. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov 01; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 18. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa EA, Ahmed AG.
    Fertil Steril; 1993 May 01; 59(5):998-1002. PubMed ID: 8486202
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.